Study of the Environmental Factors Modulating Children Immune Response in Northern Senegal

NCT01545115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2012-03-13

No results posted yet for this study

Summary

Longitudinal survey in Northern Senegal to investigate the environmental factors modulating the immune response to childhood vaccines and to malaria.

A cohort of 410 children aged 1 to 10 from 5 villages of the Senegal River Valley(Podor District) was followed-up for 18 months. During that period, 5 visits have been made to the villages to assess the immunological and nutritional status of the children.

Conditions

Sponsors & Collaborators

  • Institut Pasteur de Lille

    collaborator OTHER
  • Institut de Recherche pour le Developpement, Senegal

    collaborator OTHER
  • Institut de Recherche pour le Developpement

    collaborator OTHER_GOV
  • University of Lille Nord de France

    collaborator OTHER
  • Région Nord-Pas de Calais, France

    collaborator OTHER
  • Centre d'Infection et d'Immunité de Lille

    collaborator OTHER
  • Centre National de la Recherche Scientifique, France

    collaborator OTHER
  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV
  • Biomedical Research Center EPLS

    lead OTHER

Principal Investigators

  • Franck Remoué, PhD · Biomedical Research Center EPLS

  • Emmanuel Hermann, PhD A. Pr. · Biomedical Research Center

  • Jean Biram Sarr, PhD · Biomedical Research Center EPLS

  • Lobna Gaayeb, VetMed · Biomedical Research Center EPLS

Eligibility

Min Age
1 Year
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • Senegal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545115 on ClinicalTrials.gov